Welcome to our dedicated page for CACI INTERNATIONAL /DE/ SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CACI INTERNATIONAL /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CACI INTERNATIONAL /DE/'s regulatory disclosures and financial reporting.
CACI International (CACI) filed a Form 4 reporting that director Scott Morrison received a grant of 338 Restricted Stock Units (RSUs) on October 16, 2025. The RSUs vest in four tranches during 2026: 84 shares on January 14, 84 shares on April 14, 85 shares on July 13, and 85 shares on October 11. Following the reported transaction, 338 derivative securities were beneficially owned on a direct basis. This filing reflects routine director equity compensation and a defined vesting schedule.
CACI International Inc. (CACI) — Form 4 insider activity: Officer Eric Blazer (SVP, Corp. Controller & CAO) reported equity transactions on 10/16/2025. He acquired 98 shares of CACI common stock via the conversion of previously granted restricted stock units (Transaction Code M). To cover taxes, 30 shares were disposed at $518.23 (Code F).
Following these transactions, Blazer directly beneficially owned 180 shares. The filing also shows 99 restricted stock units remaining beneficially owned after the reported activity. The RSUs were originally granted on October 16, 2023 and vest in three equal annual installments.
CACI International Inc. director William L. Jews reported a grant of 338 restricted stock units (RSUs) on October 16, 2025. The RSUs vest as follows: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Following the grant, 338 RSUs were reported as directly owned.
CACI International (CACI) reported an insider equity award. Director Debora A. Plunkett filed a Form 4 showing an acquisition of 338 Restricted Stock Units (RSUs) on October 16, 2025. The RSUs are scheduled to vest as follows: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Following the reported transaction, the filing lists 338 derivative securities beneficially owned with direct (D) ownership.
CACI International (CACI) director Susan M. Gordon reported an equity award on Form 4: a grant of 338 restricted stock units on October 16, 2025.
The RSUs vest in four tranches: 84 shares on January 14, 2026; 84 shares on April 14, 2026; 85 shares on July 13, 2026; and 85 shares on October 11, 2026. Following the grant, 338 derivative securities were beneficially owned, held directly.
CACI International Inc. reported a Form 4 showing Director Philip O. Nolan was granted 338 Restricted Stock Units (RSUs) on October 16, 2025 (transaction code A). The RSUs vest in four tranches during 2026: 84 on January 14, 84 on April 14, 85 on July 13, and 85 on October 11. Following the reported transaction, 338 derivative securities were beneficially owned, with ownership listed as Direct.
CACI International Inc. (CACI) reported a Form 4 for Director and Chair of the Board Lisa Disbrow. On October 16, 2025, she was granted 53 shares of CACI common stock as part of her annual retainer and 492 Restricted Stock Units (RSUs).
The RSUs vest in four equal tranches of 123 shares on January 14, 2026, April 14, 2026, July 13, 2026, and October 11, 2026. Following the grant, she beneficially owned 1,987 CACI shares directly, and 492 RSUs as derivative securities.
CACI International Inc. (CACI) director Stanton D. Sloane reported an equity award on a Form 4. On October 16, 2025, he acquired 338 Restricted Stock Units (RSUs), listed as derivative securities tied to CACI common stock.
The RSUs vest in four installments during 2026: 84 shares on January 14, 84 shares on April 14, 85 shares on July 13, and 85 shares on October 11. Following this grant, the filing shows 338 derivative securities beneficially owned, held directly.
This is a routine director compensation grant disclosed under Section 16, with a defined vesting schedule that spreads delivery over the 2026 calendar year.
CACI International Inc. disclosed a Form 4 showing Director Charles L. Szews received 338 Restricted Stock Units (RSUs) on October 16, 2025.
The award vests in four installments during 2026: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. The filing lists the RSUs in Table II as acquired and directly owned, with 338 derivative securities beneficially owned following the transaction.
This is a routine equity compensation grant to a director and does not indicate cash proceeds to the company.
CACI International (CACI) reported an insider equity award. Director Ryan D. McCarthy received 338 Restricted Stock Units on October 16, 2025. These RSUs convert into shares of CACI common stock as they vest: 84 on January 14, 2026; 84 on April 14, 2026; 85 on July 13, 2026; and 85 on October 11, 2026.
The filing shows the grant as an acquisition of derivative securities with direct ownership. RSUs typically represent a form of equity compensation that settles in stock upon vesting, aligning directors’ interests with long-term shareholder value.